KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingTax ProvisionsTax Rate
Others
Ratios

Omega Healthcare Investors (OHI) EBIT (2016 - 2025)

Historic EBIT for Omega Healthcare Investors (OHI) over the last 17 years, with Q4 2025 value amounting to $223.0 million.

  • Omega Healthcare Investors' EBIT rose 2826.65% to $223.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $839.5 million, marking a year-over-year increase of 3066.42%. This contributed to the annual value of $839.5 million for FY2025, which is 3066.42% up from last year.
  • As of Q4 2025, Omega Healthcare Investors' EBIT stood at $223.0 million, which was up 2826.65% from $249.5 million recorded in Q3 2025.
  • Omega Healthcare Investors' 5-year EBIT high stood at $252.9 million for Q1 2022, and its period low was $91.9 million during Q4 2021.
  • In the last 5 years, Omega Healthcare Investors' EBIT had a median value of $163.2 million in 2022 and averaged $164.7 million.
  • As far as peak fluctuations go, Omega Healthcare Investors' EBIT skyrocketed by 60977.3% in 2021, and later tumbled by 6312.1% in 2023.
  • Over the past 5 years, Omega Healthcare Investors' EBIT (Quarter) stood at $91.9 million in 2021, then grew by 15.82% to $106.5 million in 2022, then grew by 13.87% to $121.3 million in 2023, then surged by 43.41% to $173.9 million in 2024, then increased by 28.27% to $223.0 million in 2025.
  • Its EBIT stands at $223.0 million for Q4 2025, versus $249.5 million for Q3 2025 and $200.1 million for Q2 2025.